Skip to main content

9th District

Image
Steve Cohen in the woods walking
September 5, 2025

WASHINGTON – Congressman Steve Cohen (TN-9), who as the Ranking Member of the Aviation Subcommittee authored and successfully worked to enact into law consumer protections for air travelers, today blasted the Trump Administration’s reported consideration of airline industry proposals to dismantle rules safeguarding passengers such as compensation for passengers for lengthy delays or cancellations caused by air carriers. He also criticized a request to the U.S.


Image
Steve Cohen in the woods walking
September 4, 2025

WASHINGTON – Congressman Steve Cohen (TN-9), watched Health and Human Services Secretary Robert F. Kennedy Jr. testify before the Senate Finance Committee today and released the following statement:

“Despite having been a friend of Robert F. Kennedy Jr., as a polio survivor and post-polio syndrome victim and after having watched Kennedy testify before the Senate Finance Committee, it is my duty on behalf of all polio victims past and present to ask him to resign or ask the president to remove him. 


Image
Steve Cohen
September 3, 2025

WASHINGTON – Congressman Steve Cohen (TN-9) on Tuesday evening spoke from the House floor and then signed the bipartisan discharge petition to force a vote on releasing the federal government’s records of its investigations of allegations that financier and former Trump best friend Jeffrey Epstein engaged in sexual abuse of under-aged girls. 


Image
Steve Cohen
September 3, 2025

WASHINGTON – Congressman Steve Cohen (TN-9), a senior member of the Judiciary Committee, today questioned the premise of a Republican-inspired hearing on “Europe’s Threat to American Speech and Innovation,” calling it “disingenuous.”


Image
Steve Cohen in the woods walking
August 29, 2025

WASHINGTON – Congressman Steve Cohen (TN-9) today announced that the University of Tennessee Health Science Center (UTHSC) will receive a grant of $3,078,607 from the National Institute on Aging to study the relationship between a shortage of antioxidants and age-associated cognitive decline under the direction of Dr. Megan Mulligan.

Congressman Cohen made the following statement:


Image
Steve Cohen in the woods walking
August 29, 2025

WASHINGTON – Congressman Steve Cohen (TN-9) today announced that St. Jude Children’s Research Hospital will receive two grants from the National Institutes of Health (NIH) totaling $1,486,541. The first, for $735,373, is from the National Institute of Neurological Disorders and Stroke, for advancing pantothenate kinase activation therapy, under the direction of Dr. Richard E. Lee. The second, for $751,168, is from the National Cancer Institute for the evaluation of cardiovascular outcomes among survivors of 2 Echos-2, under the direction of Dr. Matthew J. Ehrhardt.


Image
Steve Cohen in the woods walking
August 21, 2025
Congressman Cohen’s letter cites the VA’s July Workforce Dashboard showing net workforce losses of more than 8,700 veteran-facing employees in FY25.

Image
Steve Cohen in the woods walking
August 20, 2025
“I was proud to secure $5 million in Community Project Funding for Memphis International Airport, and I’m pleased to see it delivered alongside more than $45 million in additional FAA grants,” said Congressman Cohen. 

Image
Steve Cohen in the woods walking
August 14, 2025

WASHINGTON – Congressman Steve Cohen (TN-9) today announced that St. Jude Children’s Research Hospital will receive a grant of $3,262,585 from the National Institutes on Deafness and Other Communication Disorders for research on cortical mechanisms of innate frequency discrimination under the direction of Dr. Stanislav Zakharenko, director if its Division of Neural Circuits and Behavior.


Image
Steve Cohen in the woods walking
August 13, 2025

WASHINGTON – Congressman Steve Cohen (TN-9) today announced that St. Jude Children’s Research Hospital will receive a grant of $2,503,299 from the National Institute of General Medical Sciences for work on covalent inhibitors under the direction of Dr. Daniel J. Blair of the Chemical, Biology and Therapeutics Department.